{"id":"https://openalex.org/W2030227751","doi":"https://doi.org/10.1002/art.20507","title":"Characterization of pristane\u2010induced arthritis, a murine model of chronic disease: Response to antirheumatic agents, expression of joint cytokines, and immunopathology","display_name":"Characterization of pristane\u2010induced arthritis, a murine model of chronic disease: Response to antirheumatic agents, expression of joint cytokines, and immunopathology","publication_year":2004,"publication_date":"2004-10-01","ids":{"openalex":"https://openalex.org/W2030227751","doi":"https://doi.org/10.1002/art.20507","mag":"2030227751","pmid":"https://pubmed.ncbi.nlm.nih.gov/15476226"},"language":"en","primary_location":{"id":"doi:10.1002/art.20507","doi":"https://doi.org/10.1002/art.20507","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.20507","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis &amp; Rheumatism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Christopher Patten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher Patten","raw_affiliation_strings":["GlaxoSmithKline Medicines Research Centre, Stevenage, UK. Chris.5.Patten@GSK.com","GlaxoSmithKline Medicines Research Centre Stevenage UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Medicines Research Centre, Stevenage, UK. Chris.5.Patten@GSK.com","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline Medicines Research Centre Stevenage UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068484873","display_name":"Katherine Bush","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katherine Bush","raw_affiliation_strings":["GlaxoSmithKline Medicines Research Centre Stevenage UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Medicines Research Centre Stevenage UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085971622","display_name":"Inma Rioja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Inma Rioja","raw_affiliation_strings":["GlaxoSmithKline Medicines Research Centre Stevenage UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Medicines Research Centre Stevenage UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rebecca Morgan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130380","display_name":"Hutzel Women's Hospital","ror":"https://ror.org/02paek818","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109","https://openalex.org/I4210130380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Morgan","raw_affiliation_strings":["Hutzel Hospital, Detroit, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hutzel Hospital, Detroit, Michigan","institution_ids":["https://openalex.org/I4210130380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113583898","display_name":"Paul H. Wooley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130380","display_name":"Hutzel Women's Hospital","ror":"https://ror.org/02paek818","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109","https://openalex.org/I4210130380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Wooley","raw_affiliation_strings":["Hutzel Hospital, Detroit, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hutzel Hospital, Detroit, Michigan","institution_ids":["https://openalex.org/I4210130380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077005478","display_name":"John J. Trill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Trill","raw_affiliation_strings":["GlaxoSmithKline King of Prussia Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline King of Prussia Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085024998","display_name":"Paul F Life","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Life","raw_affiliation_strings":["GlaxoSmithKline Medicines Research Centre Stevenage UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Medicines Research Centre Stevenage UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1847,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.86277228,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"50","issue":"10","first_page":"3334","last_page":"3345"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pristane-induced-arthritis","display_name":"pristane-induced arthritis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chronic-inflammatory-arthritis","display_name":"chronic inflammatory arthritis","score":0.7110000252723694},{"id":"https://openalex.org/keywords/murine-arthritis-model","display_name":"murine arthritis model","score":0.8489999771118164},{"id":"https://openalex.org/keywords/autoantigens","display_name":"autoantigens","score":0.652999997138977},{"id":"https://openalex.org/keywords/autoimmunity","display_name":"autoimmunity","score":0.9279999732971191},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9210000038146973},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.8880000114440918},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prednisolone","display_name":"prednisolone","score":0.8420000076293945},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":1.0},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.8539999723434448},{"id":"https://openalex.org/keywords/diclofenac","display_name":"diclofenac","score":0.9300000071525574},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":1.0},{"id":"https://openalex.org/keywords/p38-mapk-inhibitor","display_name":"p38 MAPK inhibitor","score":0.9380000233650208},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9470000267028809},{"id":"https://openalex.org/keywords/soluble-tnf-receptors","display_name":"soluble TNF receptors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/antirheumatic-drugs","display_name":"antirheumatic drugs","score":0.7409999966621399},{"id":"https://openalex.org/keywords/immunopathology","display_name":"immunopathology","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.751975417137146},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.7495952248573303},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7214571237564087},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.6995585560798645},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.6142708659172058},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6131141781806946},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6089688539505005},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.5877753496170044},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5626003742218018},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42359402775764465},{"id":"https://openalex.org/C2778917330","wikidata":"https://www.wikidata.org/wiki/Q1274464","display_name":"Polyarthritis","level":3,"score":0.41362425684928894},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.32324931025505066},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.316566526889801}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001169","descriptor_name":"Arthritis, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007596","descriptor_name":"Joints","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013729","descriptor_name":"Terpenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048051","descriptor_name":"p38 Mitogen-Activated Protein Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/art.20507","doi":"https://doi.org/10.1002/art.20507","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.20507","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis &amp; Rheumatism","raw_type":"journal-article"},{"id":"pmid:15476226","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15476226","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis and rheumatism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1525936285","https://openalex.org/W1541495845","https://openalex.org/W1765755229","https://openalex.org/W1831778092","https://openalex.org/W1934022467","https://openalex.org/W1974131493","https://openalex.org/W1980196672","https://openalex.org/W1981916590","https://openalex.org/W1997162630","https://openalex.org/W2000905666","https://openalex.org/W2005596286","https://openalex.org/W2006780907","https://openalex.org/W2017757267","https://openalex.org/W2029385681","https://openalex.org/W2032731042","https://openalex.org/W2033077711","https://openalex.org/W2084709188","https://openalex.org/W2085807260","https://openalex.org/W2092718923","https://openalex.org/W2098767548","https://openalex.org/W2108661128","https://openalex.org/W2130532965","https://openalex.org/W2136430968","https://openalex.org/W2147852588","https://openalex.org/W2156226284","https://openalex.org/W2160013986","https://openalex.org/W2164578725","https://openalex.org/W2282770085","https://openalex.org/W2305857834","https://openalex.org/W2323601729","https://openalex.org/W2328587823","https://openalex.org/W2336588424","https://openalex.org/W2410354473","https://openalex.org/W4313341437"],"related_works":["https://openalex.org/W1936861057","https://openalex.org/W2397788451","https://openalex.org/W2277255470","https://openalex.org/W2462820250","https://openalex.org/W2038072513","https://openalex.org/W7061259729","https://openalex.org/W1600347890","https://openalex.org/W1997162630","https://openalex.org/W2436180064","https://openalex.org/W2394388710"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"characterize":[2],"chronic":[3,37,230],"murine":[4,131,185,227],"pristane-induced":[5],"arthritis":[6,174,182,232],"(PIA)":[7],"with":[8,31,107],"regard":[9],"to":[10,13,34,50,91,102,140,250],"the":[11,67,141,173,181,197,205,211,221,248,259],"response":[12,249],"antirheumatic":[14,252],"agents,":[15],"expression":[16,198],"levels":[17,68],"of":[18,53,69,105,149,199,223,229,240,262],"proinflammatory":[19,70],"cytokines,":[20,244],"and":[21,47,79,85,116,123,130,137,155,168,202,208,236,245,265],"immunopathologic":[22,263],"features.":[23],"METHODS:":[24],"Male":[25],"DBA/1":[26],"mice":[27],"were":[28,57,61,89,98,157],"injected":[29],"intraperitoneally":[30],"pristane":[32],"oil":[33],"induce":[35],"a":[36,51,118,146,188,226],"polyarthritis,":[38],"which":[39],"was":[40,177],"monitored":[41],"by":[42,81,233],"visual":[43],"scoring.":[44],"Serum":[45],"antibody":[46],"splenocyte":[48],"responses":[49,139],"panel":[52],"putative":[54,142],"joint-derived":[55],"autoantigens":[56,144],"measured.":[58],"Whole":[59],"paws":[60],"evaluated":[62],"postmortem":[63],"for":[64,100,258],"changes":[65],"in":[66,151,161,179,204,247,268],"cytokines":[71],"tumor":[72],"necrosis":[73],"factor":[74],"alpha":[75],"(TNFalpha),":[76],"interleukin-1beta":[77],"(IL-1beta),":[78],"IL-6":[80,156,203],"enzyme-linked":[82],"immunosorbent":[83],"assay,":[84],"standard":[86],"histopathology":[87],"techniques":[88],"used":[90],"determine":[92],"joint":[93,143,214,243],"structural":[94],"changes.":[95],"Therapeutic":[96],"studies":[97],"performed":[99],"up":[101],"8":[103],"weeks":[104],"dosing":[106],"prednisolone,":[108],"methotrexate,":[109,165],"3":[110],"nonsteroidal":[111],"antiinflammatory":[112],"drugs":[113],"(celecoxib,":[114],"diclofenac,":[115],"indomethacin),":[117],"p38":[119],"MAPK":[120],"inhibitor,":[121],"SB242235,":[122],"human":[124],"soluble":[125],"TNF":[126],"receptor":[127],"(sTNFR;":[128],"etanercept)":[129],"sTNFR":[132,186],"fusion":[133],"proteins.":[134],"RESULTS:":[135],"Antibody":[136],"cellular":[138,235],"revealed":[145],"broad":[147],"extent":[148],"autoimmunity":[150],"PIA.":[152],"TNFalpha,":[153,200],"IL-1beta,":[154,201],"all":[158,170],"persistently":[159],"up-regulated":[160],"PIA":[162,224,254],"joints.":[163,206],"Prednisolone,":[164],"celecoxib,":[166],"indomethacin,":[167],"SB242235":[169],"significantly":[171,195],"reduced":[172,196],"scores.":[175],"Etanercept":[176],"ineffective":[178],"reducing":[180],"scores,":[183],"whereas":[184],"produced":[187],"significant,":[189],"but":[190],"nonsustained,":[191],"benefit.":[192],"Only":[193],"prednisolone":[194],"Prednisolone":[207],"methotrexate":[209],"demonstrated":[210],"most":[212],"effective":[213],"protection.":[215],"CONCLUSION:":[216],"We":[217],"have":[218],"markedly":[219],"extended":[220],"characterization":[222],"as":[225],"model":[228],"inflammatory":[231],"demonstrating":[234],"humoral":[237],"autoantigenicity,":[238],"elevation":[239],"clinically":[241],"precedented":[242],"variation":[246],"several":[251],"therapies.":[253],"offers":[255],"significant":[256],"potential":[257],"long-term":[260],"study":[261],"mechanisms":[264],"novel":[266],"therapies":[267],"rheumatoid":[269],"arthritis.":[270]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
